SFTPD and interstitial lung disease: We used this model to reveal that serum SP‐D is a suitable marker of lung damage in RA‐ILD (Figure S1 and Figure 3K), similar to serum SP‐A, SP‐D and Krebs von den Lungen‐6 as markers of idiopathic interstitial pneumonias in humans.33